Table 3.
Comparison of procedural parameters among the control (warfarin), dabigatran, rivaroxaban and apixaban groups
| Procedural variables | Warfarin | Dabigatran | Rivaroxaban | Apixaban | P value |
|---|---|---|---|---|---|
| N = 90 | N = 90 | N = 90 | N = 90 | ||
| Presenting rhythm | |||||
| Sinus rhythm | 59 % (53/90) | 57 % (51/90) | 58 % (52/90) | 62 % (56/90) | 0.88 |
| AF/AFL | 41 % (37/90) | 43 % (39/90) | 42 % (38/90) | 38 % (34/90) | |
| Acute success | 98 % (88/90) | 98 % (88/90) | 98 % (88/90) | 99 % (89/90) | 0.99 |
| Procedure time (min) | 110 ± 24 | 106 ± 24 | 105 ± 18 | 105 ± 20 | 0.41 |
| Fluoroscopy time (min) | 33 ± 9 | 33 ± 10 | 33 ± 6 | 33 ± 8 | 0.21 |
| RF time (min) | 35 ± 8 | 33 ± 8 | 33 ± 6 | 33 ± 8 | 0.20 |
| Intraprocedural cardioversion | 32 % (29/90) | 29 % (26/90) | 32 % (29/90) | 31 % (28/90) | 0.96 |
| PVAI success | 100 % (90/90) | 100 % (90/90) | 100 % (90/90) | 100 % (90/90) | 1 |
Values are presented as mean ± standard deviation
AF atrial fibrillation, AFL atrial flutter, PVAI pulmonary vein atrium isolation, RF radiofrequency